Searched for
SWISS PHARMA COMPANIES
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- Roche Pharma commits 1.5 billion Swiss franc investment in India over next five yearsSwiss healthcare major Roche Pharma is committing 1.5 billion Swiss Francs to India over the next five years, focusing on core businesses a...
- Indian pharma firms not copying products, India respect IP rights, says GoyalCommerce and Industry Minister Piyush Goyal refuted claims that Indian pharmaceutical firms copy Swiss products, calling it a long-standing...
- Novartis launches new share buyback of up to $15 blnThe Swiss pharma company confirmed it expected sales to grow by 4% or more through 2026. Its capital allocation strategy aims to combine in...
- Switzerland looking at 'new situation' after US backs patent rules waiver for COVID vaccinesIn October 2020, India and South Africa submitted a proposal suggesting a waiver for all WTO ((World Trade Organization) members on the imp...
- Strides Pharma buys 70% in Swiss companyThe acquisition further strengthens Strides' footprint in continental Europe.
- Swiss pharma company Roche faces probe for blocking cheaper cancer drugsThe probe has been ordered in response to a complaint filed by Bengaluru-based Biocon and US firm Mylan, who together sell biosimilars of t...
- Drug firm Venus Remedies gets nod to market generic meropenem in SwitzerlandThe company has received marketing authorisation from Swiss drug authority 'Swissmedic' through its German arm Venus Pharma GmbH for merope...
- India based Venus Remedies gets market authorisation for oncology drugs from Swiss authorityChandigarh based pharma company Venus Remedies gets green signal for maket authorisation of oncology drugs from Swiss drug authority
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Jupiter Biosciences in talks to buy Swiss co; stock upJupiter Biosciences is in advanced discussion to buy privately-held Swiss pharma company SynphaBase for about $10 million to boost drug res...
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
- Pharma giant Roche starts cost-cutting programmeSwiss pharmaceutical giant Roche said on Friday it was launching a cost-cutting programme which could lead to job cuts
- Delhi High Court dismisses Roche plea on patentThe Delhi High Court on Friday allowed Indian pharmaceutical company Cipla to manufacture and sell the generic version of patented lung can...
- HC restrains Cipla from exporting anti-cancer drugThe Delhi High Court on Tuesday restrained pharma major Cipla from exporting ‘Tarceva’ to those countries where Swiss company Hoffmann La R...
- HC restrains Cipla from exporting anti-cancer drugThe Delhi High Court today restrained pharma major Cipla from exporting 'Tarceva' to those countries where Swiss company Hoffmann La Roche ...
- Delhi HC refuses relief to Swiss Company La Roche against CiplaThe Delhi High Court has refused to grant relief to Swiss pharma company Hoffmann La Roche, which sought restraining Cipla from manufacturi...
- Sun settles patent row with NovartisSun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute ove...
- Sun, Novartis settle Exelon drug disputeSun Pharmaceutical has reached an out-of-court settlement with Novartis in the US with regard to a patent dispute over the Swiss drug major...
- Swiss may not take Novartis to WTOThe judicial snub to Swiss pharma major Novartis by the Madras High Court is unlikely to send the Swiss government to the World Trade Organ...
Load More
